Toronto Dominion Bank
AGN

Toronto Dominion Bank’s Allergan plc AGN Stock Holding History

Toronto Dominion Bank’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,800
Closed -$151K – 1766
2019
Q2 		$151K Sell
1,800
-75,700
-98% -$10.5M ﹤0.01% 1127
2019
Q1 		$11.3M Sell
77,500
-17,800
-19% -$2.58M 0.02% 455
2018
Q4 		$12.7M Buy
+95,300
New +$15.6M 0.02% 346
2018
Q3 		– Sell
-95,000
Closed -$15.8M – 1661
2018
Q2 		$15.8M Buy
95,000
+45,000
+90% +$7.22M 0.03% 328
2018
Q1 		$8.41M Buy
+50,000
New +$8.39M 0.02% 446

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Toronto Dominion Bank's AGN Position: Q2 2020 in Review

Toronto Dominion Bank sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 252,630 shares — an estimated $44.7M sold.

Toronto Dominion Bank first reported a position in AGN in Q4 2013 and held it in 24 quarters. The position peaked at $60M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Toronto Dominion Bank reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Toronto Dominion Bank sold 252,630 Allergan plc shares in Q2 2020, an estimated $44.7M.
  • Toronto Dominion Bank first reported a position in Allergan plc in Q4 2013 and held it in 24 quarters.
  • Toronto Dominion Bank's Allergan plc position peaked at $60M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Toronto Dominion Bank's 13F filing for Q2 2020, filed 7 Aug 2020.